Phesi Releases Results of Global Analysis of Clinical Trials Conducted in 2021

Article

Analysis shows breast cancer was the most extensively studied disease area in previous year.

Phesi has released the results of its global analysis of all clinical trials conducted in 2021. The data show that breast cancer was the most studied disease area, followed by COVID-19. Overall, oncology had a strong presence in the top five, which also included non-small cell lung cancer, solid tumors, and multiple myeloma.

Read more about the analysis here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.